Along this line, high infiltration by CD68(+)PCNA(+) macrophages is associated with decreased recurrence-free survival (RFS) in patients with invasive breast carcinoma who received neoadjuvant chemotherapy [26]. This evidence concerns the gene CD68 and invasive breast carcinoma.